Cargando…
The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
The use of oncolytic viruses has received considerable attention in recent years and many viruses have proved to be effective against a variety of cancer models and a few are currently being used in clinical trials. However, the possible emergence and outcome of virus-resistant tumour cells has not...
Autores principales: | Alain, T, Kim, M, Johnston, R N, Urbanski, S, Kossakowska, A E, Forsyth, P A, Lee, P W K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360720/ https://www.ncbi.nlm.nih.gov/pubmed/17047650 http://dx.doi.org/10.1038/sj.bjc.6603363 |
Ejemplares similares
-
Attenuated reovirus displays oncolysis with reduced host toxicity
por: Kim, M, et al.
Publicado: (2011) -
Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms
por: Gujar, S A, et al.
Publicado: (2014) -
Oncolytic Reovirus in Canine Mast Cell Tumor
por: Hwang, Chung Chew, et al.
Publicado: (2013) -
Past, Present and Future of Oncolytic Reovirus
por: Müller, Louise, et al.
Publicado: (2020) -
Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy
por: Kumar, Vishnupriyan, et al.
Publicado: (2021)